Tvedt, T.H.A.; Rose-John, S.; Tsykunova, G.; Ahmed, A.B.; Gedde-Dahl, T.; Ersvær, E.; Bruserud, Ø.
IL-6 Responsiveness of CD4+ and CD8+ T Cells after Allogeneic Stem Cell Transplantation Differs between Patients and Is Associated with Previous Acute Graft versus Host Disease and Pretransplant Antithymocyte Globulin Therapy. J. Clin. Med. 2022, 11, 2530.
https://doi.org/10.3390/jcm11092530
AMA Style
Tvedt THA, Rose-John S, Tsykunova G, Ahmed AB, Gedde-Dahl T, Ersvær E, Bruserud Ø.
IL-6 Responsiveness of CD4+ and CD8+ T Cells after Allogeneic Stem Cell Transplantation Differs between Patients and Is Associated with Previous Acute Graft versus Host Disease and Pretransplant Antithymocyte Globulin Therapy. Journal of Clinical Medicine. 2022; 11(9):2530.
https://doi.org/10.3390/jcm11092530
Chicago/Turabian Style
Tvedt, Tor Henrik Anderson, Stefan Rose-John, Galina Tsykunova, Aymen Bushra Ahmed, Tobias Gedde-Dahl, Elisabeth Ersvær, and Øystein Bruserud.
2022. "IL-6 Responsiveness of CD4+ and CD8+ T Cells after Allogeneic Stem Cell Transplantation Differs between Patients and Is Associated with Previous Acute Graft versus Host Disease and Pretransplant Antithymocyte Globulin Therapy" Journal of Clinical Medicine 11, no. 9: 2530.
https://doi.org/10.3390/jcm11092530
APA Style
Tvedt, T. H. A., Rose-John, S., Tsykunova, G., Ahmed, A. B., Gedde-Dahl, T., Ersvær, E., & Bruserud, Ø.
(2022). IL-6 Responsiveness of CD4+ and CD8+ T Cells after Allogeneic Stem Cell Transplantation Differs between Patients and Is Associated with Previous Acute Graft versus Host Disease and Pretransplant Antithymocyte Globulin Therapy. Journal of Clinical Medicine, 11(9), 2530.
https://doi.org/10.3390/jcm11092530